CDKN2B-AS1 and lung carcinoma: Therefore, we aimed to investigate whether ANRIL could modulate the HR repair pathway through the miR-7-5p/PARP1 axis in lung cancer cells, thereby altering the radiosensitivity of lung cancer cells.